1.35
Finanzdaten der Pliant Therapeutics Inc-Aktie (PLRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
|
|
38.00%
28.27
|
45.59 | 58.94 | 62.01 | 60.64 |
| Operating Income/Loss |
38.00%
-28.27
|
-45.59 | -58.94 | -62.01 | -60.64 |
| Income/Loss From Continuing Operations Before Tax |
39.26%
-26.30
|
-43.30 | -56.17 | -57.76 | -55.85 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
39.26%
-26.30
|
-43.30 | -56.17 | -57.76 | -55.85 |
|
|
39.26%
-26.30
|
-43.30 | -56.17 | -57.76 | -55.85 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.03%
61.41
|
61.39 | 61.22 | 60.73 | 60.38 |
| Diluted Average Shares |
0.03%
61.41
|
61.39 | 61.22 | 60.73 | 60.38 |
| Basic Earnings Per Share |
39.44%
-0.43
|
-0.71 | -0.92 | -0.95 | -0.92 |
| Diluted Earnings Per Share |
39.44%
-0.43
|
-0.71 | -0.92 | -0.95 | -0.92 |
| Common Stock Dividends |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):